{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T14:09:36Z","timestamp":1774447776426,"version":"3.50.1"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T00:00:00Z","timestamp":1675814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T00:00:00Z","timestamp":1675814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urogynecol J"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s00192-023-05474-9","type":"journal-article","created":{"date-parts":[[2023,2,8]],"date-time":"2023-02-08T17:04:41Z","timestamp":1675875881000},"page":"1823-1829","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Risk of overactive bladder after hysterectomy for uterine fibroids"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5478-634X","authenticated-orcid":false,"given":"Jin-Sung","family":"Yuk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3567-0816","authenticated-orcid":false,"given":"Jun Ho","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,8]]},"reference":[{"issue":"6","key":"5474_CR1","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/j.eururo.2019.02.038","volume":"75","author":"B Peyronnet","year":"2019","unstructured":"Peyronnet B, Mironska E, Chapple C, et al. A comprehensive review of overactive bladder pathophysiology: on the way to tailored treatment. Eur Urol. 2019;75(6):988\u20131000.","journal-title":"Eur Urol"},{"issue":"6","key":"5474_CR2","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/j.eururo.2006.09.019","volume":"50","author":"DE Irwin","year":"2006","unstructured":"Irwin DE, Milsom I, Hunskaar S, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol. 2006;50(6):1306\u201315.","journal-title":"Eur Urol"},{"issue":"20","key":"5474_CR3","doi-asserted-by":"publisher","first-page":"e25761","DOI":"10.1097\/MD.0000000000025761","volume":"100","author":"X-D Lin","year":"2021","unstructured":"Lin X-D, Lin N, Ke Z-B, Xu N, Jiang P, Li H. Effects of overactive bladder syndrome on female sexual function. Medicine. 2021;100(20);e25761.","journal-title":"Medicine"},{"issue":"2","key":"5474_CR4","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.mayocp.2019.11.024","volume":"95","author":"R Raju","year":"2020","unstructured":"Raju R, Linder BJ. Evaluation and treatment of overactive bladder in women. Mayo Clin Proc. 2020;95(2):370\u20137.","journal-title":"Mayo Clin Proc"},{"issue":"7394","key":"5474_CR5","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1136\/bmj.326.7394.841","volume":"326","author":"P Herbison","year":"2003","unstructured":"Herbison P, Hay-Smith J, Ellis G, Moore K. Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder: systematic review. BMJ. 2003;326(7394):841.","journal-title":"BMJ"},{"issue":"3","key":"5474_CR6","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.eururo.2008.06.047","volume":"54","author":"CR Chapple","year":"2008","unstructured":"Chapple CR, Khullar V, Gabriel Z, Muston D, Bitoun CE, Weinstein D. The effects of antimuscarinic treatments in overactive bladder: an update of a systematic review and meta-analysis. Eur Urol. 2008;54(3):543\u201362.","journal-title":"Eur Urol"},{"key":"5474_CR7","doi-asserted-by":"publisher","unstructured":"Solifenacin and darifenacin for overactive bladder. Obstet Gynecol. 2005;106(2):401\u20132. https:\/\/doi.org\/10.1097\/01.AOG.0000173816.33966.ed.","DOI":"10.1097\/01.AOG.0000173816.33966.ed"},{"issue":"3","key":"5474_CR8","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1097\/SPV.0000000000000423","volume":"23","author":"TN Thomas","year":"2017","unstructured":"Thomas TN, Walters MD. AUGS consensus statement: association of anticholinergic medication use and cognition in women with overactive bladder. Female Pelvic Med Reconstr Surg. 2017;23(3):177\u20138.","journal-title":"Female Pelvic Med Reconstr Surg"},{"issue":"1","key":"5474_CR9","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/nau.23863","volume":"38","author":"J Wang","year":"2019","unstructured":"Wang J, Zhou Z, Cui Y, et al. Meta-analysis of the efficacy and safety of mirabegron and solifenacin monotherapy for overactive bladder. Neurourol Urodyn. 2019;38(1):22\u201330.","journal-title":"Neurourol Urodyn"},{"issue":"2","key":"5474_CR10","doi-asserted-by":"publisher","first-page":"85","DOI":"10.4274\/jus.galenos.2019.2533","volume":"6","author":"\u00d6 Acar","year":"2019","unstructured":"Acar \u00d6, Erton ML, Tarcan T. Insights into the management of overactive bladder: what difference can mirabegron make? J Urol Surg. 2019;6(2):85.","journal-title":"J Urol Surg"},{"issue":"1","key":"5474_CR11","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1067\/mob.2003.99","volume":"188","author":"DD Baird","year":"2003","unstructured":"Baird DD, Dunson DB, Hill MC, Cousins D, Schectman JM. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol. 2003;188(1):100\u20137.","journal-title":"Am J Obstet Gynecol"},{"issue":"7","key":"5474_CR12","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1089\/jwh.2020.8398","volume":"30","author":"M Lee","year":"2021","unstructured":"Lee M, Chung Y-J, Kim H-K, et al. Estimated prevalence and incidence of uterine leiomyoma, and its treatment trend in south Korean women for 12 years: a national population-based study. J Womens Health. 2021;30(7):1038\u201346.","journal-title":"J Womens Health"},{"issue":"2","key":"5474_CR13","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/S1701-2163(15)30338-8","volume":"37","author":"GA Vilos","year":"2015","unstructured":"Vilos GA, Allaire C, Laberge P-Y, et al. The management of uterine leiomyomas. J Obstet Gynaecol Can. 2015;37(2):157\u201378.","journal-title":"J Obstet Gynaecol Can"},{"issue":"22","key":"5474_CR14","doi-asserted-by":"publisher","first-page":"5335","DOI":"10.3390\/jcm10225335","volume":"10","author":"OS Madueke-Laveaux","year":"2021","unstructured":"Madueke-Laveaux OS, Elsharoud A, Al-Hendy A. What we know about the long-term risks of hysterectomy for benign indication\u2014a systematic review. J Clin Med. 2021;10(22):5335.","journal-title":"J Clin Med"},{"issue":"10","key":"5474_CR15","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1007\/s00192-018-3796-y","volume":"30","author":"P-C Li","year":"2019","unstructured":"Li P-C, Huang H-K, Ding D-C. Hysterectomy associated with de novo lower urinary tract symptoms in a Taiwanese population: a nationwide, population-based study. Int Urogynecol J. 2019;30(10):1711\u20137.","journal-title":"Int Urogynecol J"},{"key":"5474_CR16","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.ejogrb.2016.01.008","volume":"198","author":"S Selcuk","year":"2016","unstructured":"Selcuk S, Cam C, Asoglu MR, et al. Effect of simple and radical hysterectomy on quality of life\u2013analysis of all aspects of pelvic floor dysfunction. Eur J Obstet Gynecol Reprod Biol. 2016;198:84\u20138.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"5","key":"5474_CR17","doi-asserted-by":"publisher","first-page":"102355","DOI":"10.1016\/j.jogoh.2022.102355","volume":"51","author":"E Berujon","year":"2022","unstructured":"Berujon E, Thubert T, Fauvet R, Villot A, Pizzoferrato A-C. Impact of uterine fibroid surgery on lower urinary tract symptoms. J Gynecol Obstet Human Reprod. 2022;51(5):102355.","journal-title":"J Gynecol Obstet Human Reprod"},{"issue":"2","key":"5474_CR18","doi-asserted-by":"publisher","first-page":"153.e1","DOI":"10.1016\/j.ajog.2008.03.054","volume":"199","author":"KA Tikkinen","year":"2008","unstructured":"Tikkinen KA, Auvinen A, Tiitinen A, Valpas A, Johnson TM II, Tammela TL. Reproductive factors associated with nocturia and urinary urgency in women: a population-based study in Finland. Am J Obstet Gynecol. 2008;199(2):153.e1\u201312.","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"5474_CR19","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1007\/s00192-003-1097-5","volume":"14","author":"D Altman","year":"2003","unstructured":"Altman D, L\u00f3pez A, Falconer C, Zetterstr\u00f6m J. The impact of hysterectomy on lower urinary tract symptoms. Int Urogynecol J. 2003;14(6):418\u201323.","journal-title":"Int Urogynecol J"},{"key":"5474_CR20","doi-asserted-by":"publisher","first-page":"e2014008","DOI":"10.4178\/epih\/e2014008","volume":"36","author":"L Kim","year":"2014","unstructured":"Kim L, Kim J-A, Kim S. A guide for the utilization of health insurance review and assessment service national patient samples. Epidemiol Health. 2014;36:e2014008.","journal-title":"Epidemiol Health"},{"issue":"2","key":"5474_CR21","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1097\/GME.0000000000001438","volume":"27","author":"M Ulin","year":"2020","unstructured":"Ulin M, Ali M, Chaudhry ZT, Al-Hendy A, Yang Q. Uterine fibroids in menopause and perimenopause. Menopause. 2020;27(2):238.","journal-title":"Menopause"},{"issue":"1","key":"5474_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-022-10088-0","volume":"12","author":"S Hwang","year":"2022","unstructured":"Hwang S, Kang SW, Choi KJ, et al. Early menopause is associated with increased risk of retinal vascular occlusions: a nationwide cohort study. Sci Rep. 2022;12(1):1\u201310.","journal-title":"Sci Rep"},{"issue":"1","key":"5474_CR23","doi-asserted-by":"publisher","first-page":"305","DOI":"10.21873\/anticanres.13112","volume":"39","author":"J-R Li","year":"2019","unstructured":"Li J-R, Wang S-S, Lin C-H, De Groat WC, Cheng C-L. Positive association of male overactive bladder symptoms and androgen deprivation: a nationwide population-based cohort study. Anticancer Res. 2019;39(1):305\u201311.","journal-title":"Anticancer Res"},{"issue":"28","key":"5474_CR24","doi-asserted-by":"publisher","first-page":"e4107","DOI":"10.1097\/MD.0000000000004107","volume":"95","author":"C-L Cheng","year":"2016","unstructured":"Cheng C-L, Li J-R, Lin C-H, de Groat WC. Positive association of female overactive bladder symptoms and estrogen deprivation: a nationwide population-based cohort study in Taiwan. Medicine. 2016;95(28):e4107.","journal-title":"Medicine"},{"issue":"8","key":"5474_CR25","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1111\/j.1368-5031.2005.00617.x","volume":"59","author":"F Haab","year":"2005","unstructured":"Haab F, Castro-Diaz D. Persistence with antimuscarinic therapy in patients with overactive bladder. Int J Clin Pract. 2005;59(8):931\u20137.","journal-title":"Int J Clin Pract"},{"issue":"6","key":"5474_CR26","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/aje\/kwq433","volume":"173","author":"H Quan","year":"2011","unstructured":"Quan H, Li B, Couris CM, Fushimi K, Graham P, Hider P, et al. Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173(6):676\u201382.","journal-title":"Am J Epidemiol"},{"issue":"7","key":"5474_CR27","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/0002-9378(81)90710-9","volume":"141","author":"CS Iosif","year":"1981","unstructured":"Iosif CS, Batra S, Ek A, \u00c5stedt B. Estrogen receptors in the human female lower urinary tract. Am J Obstet Gynecol. 1981;141(7):817\u201320.","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"5474_CR28","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s001920170074","volume":"12","author":"E Versi","year":"2001","unstructured":"Versi E, Harvey M-A, Cardozo L, Brincat M, Studd J. Urogenital prolapse and atrophy at menopause: a prevalence study. Int Urogynecol J. 2001;12(2):107\u201310.","journal-title":"Int Urogynecol J"},{"issue":"6","key":"5474_CR29","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1016\/0002-9378(92)91562-O","volume":"166","author":"JO DeLancey","year":"1992","unstructured":"DeLancey JO. Anatomic aspects of vaginal eversion after hysterectomy. Am J Obstet Gynecol. 1992;166(6):1717\u201328.","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"5474_CR30","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1111\/j.0001-6349.2005.00742.x","volume":"84","author":"CP Maas","year":"2005","unstructured":"Maas CP, Kenter GG, Trimbos JB, Deruiter MC. Anatomical basis for nerve-sparing radical hysterectomy: immunohistochemical study of the pelvic autonomic nerves. Acta Obstet Gynecol Scand. 2005;84(9):868\u201374.","journal-title":"Acta Obstet Gynecol Scand"}],"container-title":["International Urogynecology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-023-05474-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00192-023-05474-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00192-023-05474-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T05:03:37Z","timestamp":1691643817000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00192-023-05474-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,8]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["5474"],"URL":"https:\/\/doi.org\/10.1007\/s00192-023-05474-9","relation":{},"ISSN":["0937-3462","1433-3023"],"issn-type":[{"value":"0937-3462","type":"print"},{"value":"1433-3023","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,8]]},"assertion":[{"value":"19 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}